Clinical Trials Logo

Clinical Trial Summary

Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04964739
Study type Interventional
Source Medical University of South Carolina
Contact Kevin Branson
Phone 843-792-0493
Email bransonk@musc.edu
Status Recruiting
Phase N/A
Start date November 15, 2021
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04106336 - Cortical Excitability and Role of rTMS in Cannabis Use Disorder Early Phase 1
Not yet recruiting NCT06225232 - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study Phase 2
Completed NCT04923230 - Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse N/A
Completed NCT04902092 - Brain Exercise and Addiction Trial N/A
Recruiting NCT05064319 - Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders Phase 2
Active, not recruiting NCT04567394 - Cannabis Use Disorder Treatment Study N/A